# Comparison of Neo-adjuvant Weekly Paclitaxel With or Without Carboplatin in Early Breast Cancer

> **NCT00919880** · PHASE2 · COMPLETED · sponsor: **Tao OUYANG** · enrollment: 148 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** carboplatin+ paclitaxel
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00919880
- **Lead sponsor:** Tao OUYANG
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-07
- **Final completion:** 2010-12
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2014-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00919880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00919880, "Comparison of Neo-adjuvant Weekly Paclitaxel With or Without Carboplatin in Early Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00919880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*